MENU

Contactez-nous

Alnylam Canada ULC

Alnylam Canada ULC

100%

Employees say this is a great place to work

Présentation de l'entreprise

À propos de l'entreprise

Alnylam is leading the translation of RNA interference into a whole class of innovative medicines with the potential to transform the lives of people affected with rare genetic, cardio-metabolic, hepatic infectious and central nervous system and ocular diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach for treating a wide range of severe, debilitating diseases. Founded in 2002, Alnylam is delivering on a bold vision to turn scientific possibility into reality, with a robust RNAi therapeutics platform. Alnylam is headquartered in Cambridge, MA.

TAILLE DE L'ENTREPRISE

15

SECTEUR

Biotechnology & Pharmaceuticals

Localisation

Mississauga, Ontario

Culture d’entreprise chez Alnylam Canada ULC

Comparaison des résultats avec un benchmark au Luxembourg

Plus d’informations sur le modèle

100% des employés chez Alnylam Canada ULC considèrent que c'est une entreprise où il fait bon travailler compared to 60% of employees at a typical company.

  • Alnylam Canada ULC
    • 100%
  • Sociétés du benchmark
    • 60%

Source: Great Place to Work® 2021 Global Employee Engagement Study.